🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This is an international phase III trial, with a Bayesian design, incorpora...
Status
Recruiting
Location
Los Angeles County-USC Medical Center
Start Date
2017-05-12
Trial ID
NCT02305654
This is a multicenter, randomized, controlled phase III trial to evaluate t...
Status
Suspended
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2023-12-01
Trial ID
NCT06246344
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-09-12
Trial ID
NCT06288360
Treatments Being Tested
The goal of this phase II randomized clinical trial is to compare the safet...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-05
Trial ID
NCT05842746
There is no a clear consensus regarding the optimal treatment of locally ad...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02984501
Treatments Being Tested
The overall purpose of this clinical study is to evaluate safety and effica...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-08-05
Trial ID
NCT03972527
Treatments Being Tested
The trial aimed to compare QL1706 combined with induction chemotherapy plus...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-05-04
Trial ID
NCT06749899
Treatments Being Tested